Published in Gut on August 01, 2006
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg (2008) 2.38
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69
Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol (2010) 1.37
MicroRNA profiles discriminate among colon cancer metastasis. PLoS One (2014) 1.22
Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer (2007) 1.16
What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) (2010) 1.12
Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound. World J Radiol (2009) 1.00
The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms. Cancer Res Treat (2011) 0.99
Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol (2011) 0.94
Factors in perioperative care that determine blood loss in liver surgery. HPB (Oxford) (2012) 0.93
Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res (2013) 0.93
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies. J Mol Med (Berl) (2014) 0.91
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World J Surg (2011) 0.90
Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol (2014) 0.88
Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection. World J Gastroenterol (2012) 0.88
Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) (2010) 0.88
Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia (2008) 0.88
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol (2015) 0.88
Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes. Front Oncol (2012) 0.87
Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease. Int Semin Surg Oncol (2007) 0.86
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases. Onco Targets Ther (2014) 0.86
Multisciplinary management of patients with liver metastasis from colorectal cancer. World J Gastroenterol (2016) 0.85
Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol (2014) 0.85
Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. HPB (Oxford) (2012) 0.85
Population-based review of the outcomes following hepatic resection in a Canadian health region. Can J Surg (2009) 0.85
Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World J Surg (2015) 0.83
Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. Br J Cancer (2011) 0.82
Recent trends in liver resection surgery activity and population utilization rates in English regions. HPB (Oxford) (2007) 0.82
Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases. Br J Cancer (2011) 0.82
Surgical management of colorectal liver metastases. Clin Colon Rectal Surg (2009) 0.82
Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma. World J Surg (2011) 0.82
Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer. PLoS One (2014) 0.82
Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases. J Cancer Res Clin Oncol (2008) 0.81
Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients. Mol Clin Oncol (2014) 0.81
Survival from cancers of the colon and rectum in England and Wales up to 2001. Br J Cancer (2008) 0.81
The role of 18FDG PET/CT in the management of colorectal liver metastases. HPB (Oxford) (2011) 0.81
Management of rectal cancer and liver metastatic disease: which comes first? Int J Surg Oncol (2012) 0.81
The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions. Ultrasonography (2015) 0.80
Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg (2009) 0.79
Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One (2014) 0.79
Comparison of overall survival in patients with unresectable hepatic metastases with or without transarterial chemoembolization: A Propensity Score Matching Study. Sci Rep (2016) 0.79
Evaluation of the introduction of a standardised protocol for the staging and follow-up of colorectal cancer on resection rates for liver metastases. Ann R Coll Surg Engl (2010) 0.78
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection. PLoS Genet (2016) 0.78
Perioperative ischaemia-induced liver injury and protection strategies: An expanding horizon for anaesthesiologists. Indian J Anaesth (2013) 0.77
Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE Technique. HPB Surg (2015) 0.77
Colorectal hepatic metastasis: Evolving therapies. World J Hepatol (2014) 0.77
Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up. Langenbecks Arch Surg (2014) 0.77
Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis. Surg Endosc (2016) 0.77
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76
Extended pathology reporting of resection specimens of colorectal liver metastases: the significance of a tumour pseudocapsule. HPB (Oxford) (2012) 0.76
Can the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases? Ann R Coll Surg Engl (2010) 0.75
Anatomical hepatectomy for liver metastasis from rectal adenocarcinoma presenting with intrabiliary extension: a case report. J Rural Med (2016) 0.75
Prospective diagnostic test accuracy comparison of computed tomography during arterial portography and Primovist magnetic resonance imaging in the pre-operative assessment of colorectal cancer liver metastases. HPB (Oxford) (2015) 0.75
Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives. J Contemp Brachytherapy (2016) 0.75
Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units. HPB Surg (2014) 0.75
Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis. BMC Surg (2015) 0.75
Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. HPB (Oxford) (2016) 0.75
Critical questions in the imaging of colorectal hepatic metastases. Cancer Imaging (2008) 0.75
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg (2009) 0.75
Socioeconomic status influences the likelihood but not the outcome of liver resection for colorectal liver metastasis. HPB (Oxford) (2014) 0.75
Colorectal Liver Metastases: A Never Ending Story. Ann Coloproctol (2016) 0.75
Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer. Cancer Med (2016) 0.75
Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) (2009) 0.75
Multidisciplinary approach of colorectal cancer liver metastases. World J Clin Oncol (2017) 0.75
Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer. Oncol Rev (2017) 0.75
Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer. Int J Colorectal Dis (2012) 0.75
Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes. AJR Am J Roentgenol (2017) 0.75
Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel. Eur Radiol (2017) 0.75
Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis. Oncol Lett (2017) 0.75
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol (2003) 12.82
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology (1998) 4.58
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg (1996) 4.41
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85
Factors influencing the natural history of colorectal liver metastases. Lancet (1994) 3.61
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Useless and dangerous--fine needle aspiration of hepatic colorectal metastases. BMJ (2004) 3.19
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ (2000) 3.09
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg (2000) 3.07
Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg (1994) 2.98
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Informed decision making: an annotated bibliography and systematic review. Health Technol Assess (1999) 2.74
Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol (2005) 2.66
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62
Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol (1995) 2.50
Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg (2003) 2.36
Laparoscopic liver resection. Br J Surg (2006) 2.36
Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg (1997) 2.23
Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg (1995) 2.17
Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg (2003) 2.13
Helping cancer patients disclose their concerns. Eur J Cancer (1996) 2.11
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg (2003) 2.06
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg (2006) 1.98
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology (2005) 1.84
Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am J Roentgenol (2002) 1.83
When the diagnosis is cancer: patient communication experiences and preferences. Cancer (1996) 1.82
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg (2002) 1.78
Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg (2003) 1.74
Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol (2004) 1.72
One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg (1996) 1.60
Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum (1983) 1.60
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer (2001) 1.57
The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum (1994) 1.57
The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol (1991) 1.53
Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev (2002) 1.53
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg (2001) 1.45
Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg (2002) 1.42
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg (2003) 1.42
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg (2001) 1.41
Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg (2005) 1.26
Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg (2005) 1.24
Surgical decision making for large bowel cancer metastatic to the liver. Radiology (1990) 1.19
Risk of dissemination with biopsy of colorectal liver metastases. Dis Colon Rectum (2003) 1.17
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Repeated liver resection for recurrent liver cancer. Br J Surg (1996) 1.14
Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer (2000) 1.13
Guidelines for follow up after resection of colorectal cancer. Gut (2002) 1.13
The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol (2003) 1.12
Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg (1999) 1.12
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg (2005) 1.09
Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery (1996) 1.07
Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol (2003) 1.05
Breaking bad news. Eur J Surg Oncol (1998) 1.04
Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery (1989) 1.04
Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer (1999) 0.99
Isolated splenic metastases from colon cancer. South Med J (1997) 0.98
Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg (2005) 0.97
ABC of colorectal cancer: effectiveness of follow up. BMJ (2000) 0.95
The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol (2004) 0.95
The value of laparoscopic staging for patients with colorectal metastases. Arch Surg (2003) 0.90
The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med (2002) 0.90
Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer (1995) 0.88
Management of hepatic metastases. Liver Transpl Surg (1999) 0.84
Biopsy of potentially operable hepatic colorectal metastases is not useless but dangerous. BMJ (2004) 0.83
An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. J Clin Oncol (2005) 0.80
Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol (2003) 0.78
Good behavior game: effects of individual contingencies for group consequences on disruptive behavior in a classroom. J Appl Behav Anal (1969) 11.76
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell (1992) 5.87
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Who wants a career in academic medicine? BMJ (1997) 3.36
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A (1993) 2.96
Submucous large-bowel lipomas--presentation and management. An 18-year study. Eur J Surg (1991) 2.92
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
Steps towards cost-benefit analysis of regional neurosurgical care. BMJ (1990) 2.74
Dog bites of the face: a 15 year review. Br J Plast Surg (1983) 2.51
Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell (1992) 2.50
All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell (1992) 2.49
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem (1996) 2.39
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol (1997) 2.35
Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res (1999) 2.33
Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg (1995) 2.31
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology (2001) 2.25
Atlanto-axial subluxation and cervical myelopathy in rheumatoid arthritis. Q J Med (1971) 2.20
Portfolios for assessment of paediatric specialist registrars. Med Educ (2004) 2.12
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet (1997) 2.02
A P-450-like cytochrome and a soluble terminal oxidase identified as cytochrome o from Nitrosomonas europaea. Biochem Biophys Res Commun (1965) 2.01
Humour experience in schizophrenia: relationship with executive dysfunction and psychosocial impairment. Psychol Med (2008) 1.99
Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg (2006) 1.98
Transgenic crops in natural habitats. Nature (2001) 1.97
Nurse-led management of minor illness in a GP surgery. Nurs Times (1996) 1.93
Models suggesting field experiments to test two hypotheses explaining successional diversity. Am Nat (1998) 1.91
The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively--a randomised clinical trial. Clin Nutr (2005) 1.88
The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry (1986) 1.86
A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > or =6). Pancreatology (2003) 1.85
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev (2005) 1.83
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci (2001) 1.77
Global consensus statement on menopausal hormone therapy. Climacteric (2013) 1.74
Hepatic resection for colorectal secondaries. Br J Surg (1990) 1.74
Blind percutaneous insertion of Hickman lines by a specialist team. Ann R Coll Surg Engl (2001) 1.70
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
A randomized controlled trial of an intervention designed to improve the care given in general practice to Type II diabetic patients: patient outcomes and professional ability to change behaviour. Fam Pract (1998) 1.69
Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg (2012) 1.67
Cryotherapeutic ablation of liver tumours. Br J Surg (2002) 1.63
Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br J Surg (2013) 1.62
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer (2009) 1.60
The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int (1998) 1.58
Fewer invited talks by women in evolutionary biology symposia. J Evol Biol (2013) 1.58
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer (2010) 1.57
Open cholecystectomy in the laparoscopic era. Br J Surg (2007) 1.56
Immobilisation hypercalcaemia complicating polyneuropathy in adolescent boys. J Neurol Neurosurg Psychiatry (1984) 1.56
The effect of cervical mobility on the natural history of cervical spondylotic myelopathy. J Neurol Neurosurg Psychiatry (1984) 1.55
Renal dysfunction in obstructive jaundice. Br J Surg (1995) 1.53
Cholecystectomy-related bile duct and vasculobiliary injuries. Br J Surg (2012) 1.52
(131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome. Eur J Surg Oncol (2001) 1.51
A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int (1999) 1.49
Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49
The effectiveness of exercise as treatment for vasomotor menopausal symptoms: randomised controlled trial. BJOG (2014) 1.48
Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer (2004) 1.47
Risk assessment in acute pancreatitis. Br J Surg (2009) 1.47
Pregnancy terminations after oral contraception scare. Lancet (1996) 1.47
In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol (1985) (1997) 1.46
Long-term survival following delayed presentation and resection of colorectal liver metastases. Br J Surg (2011) 1.46
Retinoic acid receptor gamma: specific immunodetection and phosphorylation. J Cell Biol (1991) 1.44
Cellular and humoral responses to measles in subacute sclerosing panencephalitis. Lancet (1969) 1.44
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol (2008) 1.42
Alopecia as a consequence of tacrolimus therapy in renal transplantation? Transplantation (1997) 1.41
Burial and seed survival in Brassica napus subsp. oleifera and Sinapis arvensis including a comparison of transgenic and non-transgenic lines of the crop. Proc Biol Sci (1997) 1.41
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg (2010) 1.39
Medical litigation in Ireland. Lancet (2001) 1.39
Persistent involuntary movements after treatment with flupenthixol. Br Med J (Clin Res Ed) (1981) 1.39
Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Mol Pharmacol (1997) 1.38
Congenital pilonidal sinus of the nose. Aust N Z J Surg (1989) 1.38
beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer (1999) 1.36
Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med (1971) 1.35
Biotin-response organicaciduria. Multiple carboxylase defects and complementation studies with propionicacidemia in cultured fibroblasts. J Clin Invest (1979) 1.33
Hypomagnesaemia in diabetes. Clin Chim Acta (1979) 1.31
Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry (1985) 1.31
Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol (1971) 1.30
Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1969) 1.29
Menorrhagia. Br Med J (Clin Res Ed) (1987) 1.28
Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol (2003) 1.28
Who gets radiotherapy? Health Trends (1990) 1.28
[3H]biotin-labeled proteins in cultured human skin fibroblasts from patients with pyruvate carboxylase deficiency. J Biol Chem (1983) 1.27
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol (2004) 1.26
Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer (1999) 1.26
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
Isolated seizures: an EEG and clinical assessment. Epilepsia (1975) 1.25
Incorporation of atmospheric oxygen in nitriteformed during ammonia oxidation by Nitrosomonas europaea. Biochim Biophys Acta (1966) 1.25
Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg (2005) 1.24
Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: no evidence for an epilepsy locus in the HLA region. Am J Hum Genet (1993) 1.23
Stable compounds of helium and neon: he@c60 and ne@c60. Science (1993) 1.22
Professional responses to innovation in clinical method: diabetes care and negotiating skills. Patient Educ Couns (1996) 1.22
Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer (2013) 1.21